/

/

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

JoVE Revista
Quimica

Se requiere una suscripción a JoVE para ver este contenido. Inicie sesión o comience su prueba gratuita.

JoVE Revista Quimica

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

9,036 Views

•

08:47 min

•

March 06, 2019

DOI:

10.3791/59063-v

DOI:

10.3791/59063-v

•

08:47 min

March 06, 2019

•

6 Views

Maria Davydova, Guillaume Dewaele Le Roi², Pierre Adumeau, Brian M. Zeglis^2,3,4

¹Department of Chemistry,Hunter College of the City University of New York, ²Ph.D. Program in Chemistry,Graduate Center of the City University of New York, ³Department of Radiology,Memorial Sloan Kettering Cancer Center, ⁴Department of Radiology,Weill Cornell Medical College

Tags

Thiol-reactive Reagents Site-specific Bioconjugation Immunoconjugates PODS Maleimide-thiol-based Bioconjugation Aminophenyl Oxadiazole Thiol Diisopropylethylamine Iodomethane Boc-protected Carboxylic Acid Dichloromethane EDCI Aniline Hydrochloric Acid Sodium Carbonate Magnesium Sulfate Ethyl Acetate Cyclohexane Carbamate M-chloroperbenzoic Acid

Read Article